Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.
about
Interleukin-11 for induction of remission in Crohn's diseaseInterleukin-11 levels in healthy and thrombocytopenic neonatesThe role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromesTreatment of lupus-induced thrombocytopenia with recombinant human interleukin-11.Risks, costs, and alternatives to platelet transfusions.Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation.Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients.Characterization of a potent human interleukin-11 agonistLow-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand diseaseMyeloid growth factors in oncology.Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions.Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window.Oral interleukin 11 as a countermeasure to lethal total-body irradiation in a murine model.Mutual cytokine crosstalk between colon cancer cells and microenvironment initiates development of distant metastases.
P2860
Q24200762-EE638A82-B357-4A03-A4DC-3DFD6FF055A6Q28200791-7C6AF959-CA75-4347-A7AF-4A5473110385Q28290383-4386DCF3-1ED7-44CF-A90E-712F1D7EEF75Q32045005-3D49C5D2-A2B3-4976-B947-ECF8FE9A9060Q33328995-CFC18229-9826-47DD-8A2C-FDB352357213Q33331970-0C8F9149-AE59-48EA-8D1B-D9EEDEB5CBA7Q33342076-63B5510B-3E8E-4C1D-B23F-C99A1F9A2F70Q33349514-B2D81652-186E-486E-B3F5-A45569F4A130Q33364151-F3351208-E76F-4AF9-9B3C-FF2B070170DDQ34909055-510568F4-C976-4BDC-81DD-9B1E28D6786FQ36181140-2C725638-AEC2-415A-AF73-AA2EEB279556Q37485709-67BF71A6-0539-4AE9-9CE6-D8218452F500Q37733614-CE9BC5B7-6825-430E-9FED-00C8AEA2BDE2Q39855237-5E9F9CC0-4839-46C1-A1B5-88D377BD214AQ43093578-8A869D62-1345-4593-90D3-AE3FA7D98C84
P2860
Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@ast
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@en
type
label
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@ast
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@en
prefLabel
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@ast
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@en
P2093
P921
P1476
Randomized placebo-controlled ...... lophosphamide and doxorubicin.
@en
P2093
B Overmoyer
F A Bailey
M W Schuster
N J Robert
P304
P356
10.1200/JCO.1997.15.11.3368
P407
P577
1997-11-01T00:00:00Z